VANGUARD GROUP INC - VINCERX PHARMA INC ownership

VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 66 filers reported holding VINCERX PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of VINCERX PHARMA INC
ValueSharesWeighting
Q3 2023$518,555
-23.3%
513,420
-1.3%
0.00%
Q2 2023$676,350
+25.0%
520,2690.0%0.00%
Q1 2023$541,080
+2.0%
520,2690.0%0.00%
Q4 2022$530,674
-26.3%
520,269
-0.4%
0.00%
Q3 2022$720,000
-5.9%
522,156
-9.9%
0.00%
Q2 2022$765,000
-71.3%
579,425
-13.0%
0.00%
Q1 2022$2,664,000
-60.0%
666,019
+1.8%
0.00%
Q4 2021$6,668,000
-22.9%
654,352
+22.3%
0.00%
Q3 2021$8,651,000
+38.7%
535,035
+11.5%
0.00%
Q2 2021$6,235,000
-17.2%
480,058
+23.1%
0.00%
Q1 2021$7,527,000389,9890.00%
Other shareholders
VINCERX PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Affinity Asset Advisors, LLC 1,492,771$1,940,6020.68%
SAGE RHINO CAPITAL LLC 1,686,937$2,193,0180.61%
Tejara Capital Ltd 233,348$303,3520.15%
SABBY MANAGEMENT, LLC 103,100$134,0300.11%
Long Focus Capital Management, LLC 1,098,753$1,428,3790.06%
KINGDON CAPITAL MANAGEMENT, L.L.C. 385,000$500,5000.05%
Sio Capital Management, LLC 102,049$132,6640.03%
Rock Springs Capital Management LP 891,719$1,159,2350.03%
Rubric Capital Management LP 354,377$460,6900.02%
Schonfeld Strategic Advisors LLC 601,645$782,1380.01%
View complete list of VINCERX PHARMA INC shareholders